exercised        1,129,062     677             -          (248)         -         -             429 
Warrants 
 exercised        1,100,000     735             -             -       (240)        -             495 
Loss and 
 comprehensive 
 loss for the 
 period                   -       -             -             -          -    (6,951)         (6,951) 
Share-based 
 compensation             -       -             -           803          -         -             803 
--------------  -----------  ------   -----------  ------------   --------   -------   ------------- 
Balance, 
 September 30, 
 2020           236,605,745  71,777         7,981         6,738      2,418   (87,562)          1,352 
Public 
 offering                 -      (2)                                                              (2  ) 
Share options 
 exercised          150,000      95             -           (44)         -         -              51 
Loss and 
 comprehensive 
 loss for the 
 period                   -       -             -             -          -    (2,147)         (2,147  ) 
Share-based 
 compensation             -       -             -            77          -         -              77 
--------------  -----------  ------   -----------  ------------   --------   -------   ------------- 
Balance, 
 December 31, 
 2020           236,755,745  71,870         7,981         6,771      2,418   (89,709)           (669  ) 
--------------  -----------  ------   -----------  ------------   --------   -------   ------------- 
Balance, 
 January 1, 
 2021           236,755,745  71,870  7,981  6,771    2,418     (89,709)        (669        ) 
Bought deal 
 offering        23,530,000   7,406      -      -    1,464           -        8,870 
Share options 
 exercised          143,333      98      -    (46)       -           -           52 
Warrants 
 exercised        7,457,330   4,983      -      -   (1,627)          -        3,356 
Warrants 
 expired                  -       -      4      -       (4)          -            - 
Loss and 
 comprehensive 
 loss for the 
 period                   -       -      -      -        -      (6,233)      (6,233) 
Share-based 
 compensation             -       -      -  1,117        -           -        1,117 
--------------  -----------  ------  -----  -----   ------   ---------   ----------  ------- 
Balance, 
 September 30, 
 2021           267,886,408  84,357  7,985  7,842    2,251     (95,942)       6,493 
--------------  -----------  ------  -----  -----   ------   ---------   ----------  ------- 
Spectral Medical Inc. 
Condensed Interim Consolidated 
Statements of Cash Flows 
(unaudited) 
--------------------------------------  -------------------------------------- 
(in thousands of Canadian dollars) 
                                          Nine-months ended September 30, 
                                             2021                 2020 
                                               $                   $ 
--------------------------------------  ---------------      -------------- 
Cash flow provided by (used in) 
Operating activities 
Loss and comprehensive loss for the 
 period                                          (6,233)             (6,951) 
Adjustments for: 
     Depreciation on right-of-use 
      asset                                          70                  70 
     Depreciation on property and 
      equipment                                     140                 140 
     Amortization of intangible asset                13                  13 
     Interest expense on lease 
      liability                                      21                  25 
     Unrealized foreign exchange loss 
      on cash                                        42                  32 
     Share-based compensation                     1,117                 803 
     Write down of property and 
      equipment to fair value                       174                   - 
     Gain on disposal of property and 
      equipment                                     (40)                 (8) 
Changes in items of working capital: 
      Trade and other receivables                  (307)                (59) 
      Inventories                                   (51)                (67) 
      Prepayments and other assets                 (403)               (257) 
      Contract asset                                  -                 519 
      Trade and other payables                     (806)                776 
      Contract liabilities                         (449)              6,183 
Net cash (used in) provided by 
 operating activities                            (6,712)              1,219 
Investing activities 
Proceeds on disposal of property and 
 equipment                                           77                  10 
Property and equipment expenditures                (401)               (215) 
Net cash used in investing activities              (324)               (205) 
Financing activities 
Proceeds from financing                          10,000               5,100 
Transaction costs paid                           (1,130)               (784) 
Warrants exercised                                3,356                 495 
Share options exercised                              52                 429 
Lease liability payments                            (84)                (81) 
Net cash provided by financing 
 activities                                      12,194               5,159 
Increase in cash                                  5,158               6,173 
Effects of exchange rate changes on 
 cash                                               (42)                (32) 
Cash, beginning of period                         5,807               1,435 
--------------------------------------  ---------------      -------------- 
Cash, end of period                              10,923               7,576 
--------------------------------------  ---------------      -----